{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:23:09Z","timestamp":1789568589848,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,8,18]],"date-time":"2011-08-18T00:00:00Z","timestamp":1313625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s00198-011-1747-2","type":"journal-article","created":{"date-parts":[[2011,8,18]],"date-time":"2011-08-18T04:38:51Z","timestamp":1313642331000},"page":"75-85","source":"Crossref","is-referenced-by-count":112,"title":["Fracture risk assessment without bone density measurement in routine clinical practice"],"prefix":"10.1007","volume":"23","author":[{"name":"for the Manitoba Bone Density Program","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. D.","family":"Leslie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. M.","family":"Lix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Oden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"McCloskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Kanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,18]]},"reference":[{"key":"1747_CR1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","volume":"285","author":"NIH Consensus Development Panel","year":"2001","unstructured":"NIH Consensus Development Panel (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785\u2013795","journal-title":"JAMA"},{"key":"1747_CR2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s001980170116","volume":"12","author":"ME Wiktorowicz","year":"2001","unstructured":"Wiktorowicz ME, Goeree R, Papaioannou A et al (2001) Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporos Int 12:271\u2013278","journal-title":"Osteoporos Int"},{"key":"1747_CR3","first-page":"591","volume":"22","author":"A Papaioannou","year":"2000","unstructured":"Papaioannou A, Wiktorowicz ME, Adachi JD et al (2000) Mortality, independence in living and re-fracture, one year following hip fracture in Canadians. J Soc Obstet Gynaecol Can 22:591\u2013597","journal-title":"J Soc Obstet Gynaecol Can"},{"key":"1747_CR4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s001980170112","volume":"12","author":"JA Kanis","year":"2001","unstructured":"Kanis JA, Oden A, Johnell O et al (2001) The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 12:417\u2013427","journal-title":"Osteoporos Int"},{"key":"1747_CR5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00198-004-1780-5","volume":"16","author":"JA Kanis","year":"2005","unstructured":"Kanis JA, Borgstrom F, De Laet C et al (2005) Assessment of fracture risk. Osteoporos Int 16:581\u2013589","journal-title":"Osteoporos Int"},{"key":"1747_CR6","unstructured":"Kanis JA, on behalf of the World Health Organization Scientific Group (2008) Assessment of osteoporosis at the primary health-care level. Technical Report, WHO Collaborating Centre for metabolic Bone Disease, University of Sheffield, UK. Available at http:\/\/www.shef.ac.uk\/FRAX"},{"key":"1747_CR7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, Johnell O, Oden A et al (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385\u2013397","journal-title":"Osteoporos Int"},{"key":"1747_CR8","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1210\/jc.2008-0926","volume":"93","author":"B Dawson-Hughes","year":"2008","unstructured":"Dawson-Hughes B (2008) A revised clinician\u2019s guide to the prevention and treatment of osteoporosis. J Clin Endocrinol Metab 93:2463\u20132465","journal-title":"J Clin Endocrinol Metab"},{"key":"1747_CR9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00198-008-0559-5","volume":"19","author":"B Dawson-Hughes","year":"2008","unstructured":"Dawson-Hughes B, Tosteson AN, Melton LJ III et al (2008) Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int 19:449\u2013458","journal-title":"Osteoporos Int"},{"key":"1747_CR10","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00198-008-0712-1","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, McCloskey EV, Johansson H et al (2008) Case finding for the management of osteoporosis with FRAX\u2014assessment and intervention thresholds for the UK. Osteoporos Int 19:1395\u20131408","journal-title":"Osteoporos Int"},{"key":"1747_CR11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00198-009-0975-1","volume":"21","author":"K Lippuner","year":"2010","unstructured":"Lippuner K, Johansson H, Kanis JA et al (2010) FRAX assessment of osteoporotic fracture probability in Switzerland. Osteoporos Int 21:381\u2013389","journal-title":"Osteoporos Int"},{"key":"1747_CR12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00198-008-0560-z","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, Burlet N, Cooper C et al (2008) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 19:399\u2013428","journal-title":"Osteoporos Int"},{"key":"1747_CR13","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1359\/jbmr.2003.18.8.1547","volume":"18","author":"S Fujiwara","year":"2003","unstructured":"Fujiwara S, Kasagi F, Masunari N et al (2003) Fracture prediction from bone mineral density in Japanese men and women. J Bone Miner Res 18:1547\u20131553","journal-title":"J Bone Miner Res"},{"key":"1747_CR14","first-page":"612","volume":"64","author":"A Neuprez","year":"2009","unstructured":"Neuprez A, Johansson H, Kanis JA et al (2009) A FRAX model for the assessment of fracture probability in Belgium. Rev Med Liege 64:612\u2013619","journal-title":"Rev Med Liege"},{"key":"1747_CR15","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1503\/cmaj.100771","volume":"182","author":"A Papaioannou","year":"2010","unstructured":"Papaioannou A, Morin S, Cheung AM et al (2010) 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 182:1864\u20131873","journal-title":"CMAJ"},{"key":"1747_CR16","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00198-007-0343-y","volume":"18","author":"JA Kanis","year":"2007","unstructured":"Kanis JA, Oden A, Johnell O et al (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033\u20131046","journal-title":"Osteoporos Int"},{"key":"1747_CR17","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00198-004-1756-5","volume":"16","author":"WD Leslie","year":"2005","unstructured":"Leslie WD, MacWilliam L, Lix L et al (2005) A population-based study of osteoporosis testing and treatment following introduction of a new bone densitometry service. Osteoporos Int 16:773\u2013782","journal-title":"Osteoporos Int"},{"key":"1747_CR18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1385\/JCD:8:1:025","volume":"8","author":"WD Leslie","year":"2005","unstructured":"Leslie WD, Caetano PA, MacWilliam LR et al (2005) Construction and validation of a population-based bone densitometry database. J Clin Densitom 8:25\u201330","journal-title":"J Clin Densitom"},{"key":"1747_CR19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bone.2007.11.001","volume":"42","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, McCloskey EV, Johansson H et al (2008) A reference standard for the description of osteoporosis. Bone 42:467\u2013475","journal-title":"Bone"},{"key":"1747_CR20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1359\/JBMR.041134","volume":"20","author":"KE Hansen","year":"2005","unstructured":"Hansen KE, Binkley N, Christian R et al (2005) Interobserver reproducibility of criteria for vertebral body exclusion. J Bone Miner Res 20:501\u2013508","journal-title":"J Bone Miner Res"},{"key":"1747_CR21","doi-asserted-by":"crossref","first-page":"JS10","DOI":"10.1097\/00005650-199906001-00005","volume":"37","author":"NP Roos","year":"1999","unstructured":"Roos NP, Shapiro E (1999) Revisiting the Manitoba Centre for Health Policy and Evaluation and its population-based health information system. Med Care 37:JS10\u2013JS14","journal-title":"Med Care"},{"key":"1747_CR22","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1345\/aph.18117","volume":"32","author":"AL Kozyrskyj","year":"1998","unstructured":"Kozyrskyj AL, Mustard CA (1998) Validation of an electronic, population-based prescription database. Ann Pharmacother 32:1152\u20131157","journal-title":"Ann Pharmacother"},{"key":"1747_CR23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1210\/jc.2006-1415","volume":"92","author":"WD Leslie","year":"2007","unstructured":"Leslie WD, Tsang JF, Caetano PA et al (2007) Effectiveness of bone density measurement for predicting osteoporotic fractures in clinical practice. J Clin Endocrinol Metab 92:77\u201381","journal-title":"J Clin Endocrinol Metab"},{"key":"1747_CR24","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1002\/jbmr.123","volume":"25","author":"WD Leslie","year":"2010","unstructured":"Leslie WD, Lix LM, Johansson H et al (2010) Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration. J Bone Miner Res 25:2350\u20132358","journal-title":"J Bone Miner Res"},{"key":"1747_CR25","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00198-010-1465-1","volume":"22","author":"LA Fraser","year":"2011","unstructured":"Fraser LA, Langsetmo L, Berger C et al (2011) Fracture prediction and calibration of a Canadian FRAX(R) tool: a population-based report from CaMos. Osteoporos Int 22:829\u2013837","journal-title":"Osteoporos Int"},{"key":"1747_CR26","first-page":"178","volume":"56","author":"K Siminoski","year":"2005","unstructured":"Siminoski K, Leslie WD, Frame H et al (2005) Recommendations for bone mineral density reporting in Canada. Can Assoc Radiol J 56:178\u2013188","journal-title":"Can Assoc Radiol J"},{"key":"1747_CR27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00198-007-0550-6","volume":"19","author":"AN Tosteson","year":"2008","unstructured":"Tosteson AN, Melton LJ III, Dawson-Hughes B et al (2008) Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 19:437\u2013447","journal-title":"Osteoporos Int"},{"key":"1747_CR28","first-page":"605","volume":"14","author":"AN Tosteson","year":"2008","unstructured":"Tosteson AN, Burge RT, Marshall DA et al (2008) Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations. Am J Manag Care 14:605\u2013615","journal-title":"Am J Manag Care"},{"key":"1747_CR29","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/sj.bjc.6602102","volume":"91","author":"JM Satagopan","year":"2004","unstructured":"Satagopan JM, Ben-Porat L, Berwick M et al (2004) A note on competing risks in survival data analysis. Br J Cancer 91:1229\u20131235","journal-title":"Br J Cancer"},{"key":"1747_CR30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","volume":"27","author":"MJ Pencina","year":"2008","unstructured":"Pencina MJ, D\u2019Agostino RB Sr, D\u2019Agostino RB Jr et al (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27:157\u2013172","journal-title":"Stat Med"},{"key":"1747_CR31","doi-asserted-by":"crossref","first-page":"751","DOI":"10.7326\/0003-4819-149-10-200811180-00009","volume":"149","author":"H Janes","year":"2008","unstructured":"Janes H, Pepe MS, Gu W (2008) Assessing the value of risk predictions by using risk stratification tables. Ann Intern Med 149:751\u2013760","journal-title":"Ann Intern Med"},{"key":"1747_CR32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00198-004-1811-2","volume":"16","author":"JA Kanis","year":"2005","unstructured":"Kanis JA, Johnell O (2005) Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int 16:229\u2013238","journal-title":"Osteoporos Int"},{"key":"1747_CR33","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00198-008-0821-x","volume":"20","author":"JR Curtis","year":"2009","unstructured":"Curtis JR, Laster A, Becker DJ et al (2009) The geographic availability and associated utilization of dual-energy X-ray absorptiometry (DXA) testing among older persons in the United States. Osteoporos Int 20:1553\u20131561","journal-title":"Osteoporos Int"},{"key":"1747_CR34","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1359\/jbmr.2004.19.6.906","volume":"19","author":"H Johansson","year":"2004","unstructured":"Johansson H, Oden A, Johnell O et al (2004) Optimization of BMD measurements to identify high risk groups for treatment\u2014a test analysis. J Bone Miner Res 19:906\u2013913","journal-title":"J Bone Miner Res"},{"key":"1747_CR35","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bone.2009.02.014","volume":"44","author":"JA Kanis","year":"2009","unstructured":"Kanis JA, Johansson H, Oden A et al (2009) Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX. Bone 44:1049\u20131054","journal-title":"Bone"},{"key":"1747_CR36","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00198-008-0786-9","volume":"20","author":"EV McCloskey","year":"2009","unstructured":"McCloskey EV, Johansson H, Oden A et al (2009) Ten-year fracture probability identifies women who will benefit from clodronate therapy\u2014additional results from a double-blind, placebo-controlled randomised study. Osteoporos Int 20:811\u2013817","journal-title":"Osteoporos Int"},{"issue":"supplement 1","key":"1747_CR37","first-page":"S103","volume":"22","author":"EV McCloskey","year":"2011","unstructured":"McCloskey EV, Lewiecki M, Kanis JA et al (2011) Denosumab reduces the risk of clinical osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX\u00ae. Osteoporos Int 22(supplement 1):S103","journal-title":"Osteoporos Int"},{"key":"1747_CR38","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.bone.2010.06.009","volume":"47","author":"JA Kanis","year":"2010","unstructured":"Kanis JA, Johansson H, Oden A et al (2010) A meta-analysis of the efficacy of raloxifene on all clinical and vertebral fractures and its dependency on FRAX. Bone 47:729\u2013735","journal-title":"Bone"},{"key":"1747_CR39","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1007\/s00198-010-1474-0","volume":"22","author":"JA Kanis","year":"2011","unstructured":"Kanis JA, Johansson H, Oden A et al (2011) A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX(\u00ae). Osteoporos Int 22:2347\u20132355","journal-title":"Osteoporos Int"},{"key":"1747_CR40","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1007\/s00198-011-1683-1","volume":"22","author":"JA Kanis","year":"2011","unstructured":"Kanis JA, Johansson H, Oden A et al (2011) Erratum to: A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX(\u00ae). Osteoporos Int 22:2357\u20132358","journal-title":"Osteoporos Int"},{"key":"1747_CR41","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1359\/jbmr.081203","volume":"24","author":"MG Donaldson","year":"2009","unstructured":"Donaldson MG, Cawthon PM, Lui LY et al (2009) Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new U.S. National Osteoporosis Foundation Guidelines. J Bone Miner Res 24:675\u2013680","journal-title":"J Bone Miner Res"},{"key":"1747_CR42","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/jbmr.55","volume":"25","author":"MG Donaldson","year":"2010","unstructured":"Donaldson MG, Cawthon PM, Lui LY et al (2010) Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US National Osteoporosis Foundation guidelines. J Bone Miner Res 25:1506\u20131511","journal-title":"J Bone Miner Res"},{"key":"1747_CR43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00198-009-1127-3","volume":"21","author":"SD Berry","year":"2010","unstructured":"Berry SD, Kiel DP, Donaldson MG et al (2010) Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis Study. Osteoporos Int 21:53\u201360","journal-title":"Osteoporos Int"},{"key":"1747_CR44","doi-asserted-by":"crossref","first-page":"793","DOI":"10.7326\/0003-4819-128-10-199805150-00001","volume":"128","author":"MC Nevitt","year":"1998","unstructured":"Nevitt MC, Ettinger B, Black DM et al (1998) The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 128:793\u2013800","journal-title":"Ann Intern Med"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-011-1747-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-011-1747-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-011-1747-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:08:40Z","timestamp":1558609720000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-011-1747-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,18]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["1747"],"URL":"https:\/\/doi.org\/10.1007\/s00198-011-1747-2","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,18]]}}}